ATH434 Reduces α‐Synuclein‐Related Neurodegeneration in a Murine Model of Multiple System Atrophy-Reference-Cited by-同舟云学术

ATH434 Reduces α‐Synuclein‐Related Neurodegeneration in a Murine Model of Multiple System Atrophy

Published:2021-07-08 Issue:11 Volume:36 Page:2605-2614
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Movement Disorders

Author:

Heras‐Garvin Antonio¹^ORCID,Refolo Violetta¹,Schmidt Claudio¹,Malfertheiner Katja¹,Wenning Gregor K.¹,Bradbury Margaret²,Stamler David²,Stefanova Nadia¹^ORCID

Affiliation:

1. Laboratory for Translational Neurodegeneration Research, Department of Neurology Medical University of Innsbruck Innsbruck Austria

2. Alterity Therapeutics Newark California USA

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.28714

Reference53 articles.

1. Multiple-System Atrophy

2. Interventional trials in atypical parkinsonism

3. Glia and alpha-synuclein in neurodegeneration: A complex interaction

4. Neuroinflammation and Glial Phenotypic Changes in Alpha-Synucleinopathies

5. From Synaptic Protein to Prion: The Long and Controversial Journey of α-Synuclein

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on multiple system atrophy;Current Opinion in Neurology;2024-06-03

2. Preclinical Validation of FTY720 and FTY720-Mitoxy in Mouse Models of Parkinsons Disease and Multiple System Atrophy (MSA): Evidence for Treating Lewy Body Disease Synucleinopathies Including MSA;Rare Neurodegenerative Disorders - New Insights [Working Title];2024-05-23

3. Toward the complete understanding of the pathogenic mechanism of clioquinol-induced subacute myelo-optic neuropathy (SMON);Folia Pharmacologica Japonica;2024-03-01

4. Recent Advances in Clinical Trials in Multiple System Atrophy;Current Neurology and Neuroscience Reports;2024-02-28

5. Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy;Pharmaceutics;2023-07-30